E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/27/2020 in the Prospect News Convertibles Daily.

New Issue: 1Life Healthcare sells upsized $275 million five-year convertibles to yield 3%, up 30%

By Abigail W. Adams

Portland, Me., May 27 – 1Life Healthcare Inc. priced an upsized $275 million of five-year convertible notes after the market close on Tuesday at par with a coupon of 3% and an initial conversion premium of 30%, according to a company press release.

Pricing came at the cheap end of talk for a coupon of 2.5% to 3% and at the midpoint of talk for an initial conversion premium of 27.5% to 32.5%, according to a market source.

Morgan Stanley & Co. LLC (lead left) and J.P. Morgan Securities LLC were bookrunners for the Rule 144A offering, which carries an upsized greenshoe of $41.25 million.

The initial size of the deal was $250 million with a greenshoe of $37.5 million.

The notes are non-callable until June 20, 2023 and then subject to a 130% hurdle. They are putable upon a fundamental change.

The notes will be settled in cash, shares or a combination of both at the company’s option.

Net proceeds are expected to be $266.6 million, or $306.7 million if the greenshoe is exercised in full.

Proceeds will be used for general corporate purposes, including working capital, business development, sales and marketing and capital expenditures, according to a company news release.

Proceeds may also be used for acquisitions or strategic investments although no current agreements exist.

1Life Healthcare is a San Francisco-based membership-based primary health care provider.

Issuer:1Life Healthcare Inc.
Securities:Convertible senior notes
Amount:$275 million
Greenshoe:$41.25 million
Maturity:June 15, 2025
Bookrunners:Morgan Stanley & Co. LLC (lead left) and J.P. Morgan Securities LLC
Coupon:3%
Price:Par
Yield:3%
Conversion premium:30%
Conversion price:$44.43
Conversion rate:22.5052
Call options:Non-callable until June 20, 2023 and then subject to a 130% hurdle
Put options:Upon a fundamental change
Pricing date:May 26
Settlement date:May 29
Distribution:Rule 144A
Talk:Coupon of 2.5% to 3% and initial conversion premium of 27.5% to 32.5%
Stock symbol:Nasdaq: ONEM
Stock price:$34.18
Market capitalization:$4.31 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.